Evidence map›Paper›PMID 40974102›Full record

ArticleAllergy2025

Tissue Distribution and Phenotype of Human Mast Cells in BRGSF and NSG-SGM3-IL15 Humanized Mice.

William P M Worrall, Nadine Serhan, Julien J Karrich, Céline El Samrout, Ruchan Ekren, Jasper B J Kamphuis, Charlotte Hateb, Edouard Leveque, Alexia Loste, Pol Andre Apoil and 2 more

Abstract readLetter
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Developments in Mast Cell Research.The Journal of allergy and clinical immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

William P M WorrallToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-2507-8173
Nadine SerhanToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0001-9870-9875
Julien J KarrichToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0001-5911-8925
Céline El SamroutToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0009-0006-0687-5651
Ruchan EkrenToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0001-6737-7281
Jasper B J KamphuisToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0002-8494-613X
Charlotte HatebToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0009-0006-9753-7243
Edouard LevequeToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-0002-729X
Alexia LosteToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.
Pol Andre ApoilToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0002-1057-4919
Nicolas GaudenzioToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0002-5648-509X
Laurent L ReberToulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-3384-6769

Funding

Agence Nationale de la RechercheArgenxEuropean Research CouncilFondation ARC for cancer research ARCDOC42022120005713Fondation du SouffleFondation pour la Recherche MédicaleInstitut National de la Santé et de la Recherche MédicaleRégion Occitanie Pyrénées-Méditerranée
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40974102
PMCPMC12590321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.